AI Donation & Transplant Resource Collaborative Launched

Exciting things are happening in the world of organ donation and transplantation! Organ Donation & Transplantation Alliance (The Alliance) is launching the AI Donation & Transplant Resource Collaborative bringing together leaders from across the country to align on how AI can improve outcomes for patients and increase efficiency for our entire ecosystem. I’m honored to be part of this conversation through my work with industry partners like CompuMed, Inc. and collaborations with transplant surgeons, physicians, and hospital teams. Together, we are reimagining what’s possible when technology, innovation, and clinical expertise intersect. This is the time to get involved and help shape the future of donation and transplant. The potential for AI to transform our field is enormous but only if we work collectively. If you’re leading or exploring AI-related projects in transplantation or donation, I encourage you to join this national effort. Your voice and expertise are needed! Learn more and see how you can participate: https://bit.ly/4ngJxpu #Transplant #OrganDonation #AI #Innovation #TheAlliance

Thrilled to share some exciting news from the PUMP Consortium 🚀 PUMP has been awarded an NIH R01 grant for our project “AI-Liver” — a groundbreaking initiative that will harness artificial intelligence to transform how we evaluate donor livers during machine perfusion. Our goal: to unlock real-time insights into organ viability and improve outcomes in liver transplantation. Grateful to our collaborators and supporters who made this possible — this is a major step toward the future of AI-driven transplant medicine. #LiverTransplant #AI #MachinePerfusion #NIH #Innovation

When innovative data collection, research, care integration, and AI come together, AI-Liver, is a groundbreaking project focused on real-time evaluation of donor liver viability and predicting transplantation outcomes using advanced AI technologies.

#AI #Healthcare #BreastCancer #ExplainableAI #Collaboration Breast cancer care is entering a new era with AI-driven precision medicine — but trust remains a challenge because of the “black box” nature of many models. In my latest research, I integrated Explainable AI (XAI) with clinical and genomic data from patients with metastatic breast cancer to recommend personalized treatments, including hormonal therapy, chemotherapy, and anti-HER2 therapy. Using a decision tree model, we achieved 99.87% accuracy with transparent reasoning, enabling both doctors and patients to trust AI recommendations. I’m now looking to collaborate with researchers, clinicians, and industry experts who are passionate about AI in healthcare and precision oncology. Together, we can make AI not just powerful, but also understandable and impactful for patients' lives.

'Glioblastoma is a highly aggressive Brain Tumour that's rapidly fatal in most patients. We are very interested and excited by novel therapeutic approaches that seek to reverse invasion and migration by Glioma stem cells in these tumours. And we are excited to see what these therapies can do for patients in the future.' - Harry Bulstrode

💡 Do you think Regenerative therapy will become common practice in the future? A clip from our trusted partner Miracle Regenerative. In this video, George shares his insights on the future of stem cell therapy and how it could transform healthcare as we know it. From recovery and longevity to personalized treatments, the possibilities are exciting. Watch, share, and join the conversation: How soon do you think stem cell therapies will be a routine part of medicine? #StemCellTherapy #FutureOfMedicine #RegenerativeMedicine #Longevity #HealthcareInnovation

🤖 Understanding how #AI can combine multiple types of data is increasingly important in oncology. 📊 The ESMO article “AI applications in oncology go beyond clinical practice” highlights how multimodal foundation models integrate EHRs, genomics, imaging, and patient-reported outcomes to provide a flexible basis for supporting clinical and research tasks. These models help clinicians interpret AI outputs and understand patient health more comprehensively. 👉 Read more about how #ArtificialIntelligence and digital tools are shaping patient care in this article in the #ESMODailyReporter: https://ow.ly/CCrH50X4fwt #HealthAI #DigitalOncology #AIOncology #ESMOAI25 Rodrigo Dienstmann

Ready for this? The AAMDSIF Bone Marrow Failure Symposium-Disease Updates and Health Equity will focus on new advances in pathophysiology, diagnosis, and clinical management of bone marrow failure diseases and hematopoietic stem cell transplantation. https://ow.ly/X11i50WEKPF

A recent Finnish registry-based study shows that overall survival among stem cell transplant (SCT) patients with multiple myeloma has improved significantly between 2013–2022. ➡️ Covering data from 1,733 patients – representing over half of Finland’s population – the study offers important insights into how novel therapies and clinical practices have impacted patient outcomes across Finland. ➡️ While treatment options continue to improve, the study also highlights the urgent need for better strategies for patients who are not eligible for transplantation. Read more: https://lnkd.in/dVetVA2N   #RWE #RealWorldEvidence #RWD #RealWorldData

At the 2025 Great Debates in Hematologic Malignancies meeting, Joshua Richter, MD, argues for the benefits of dual #maintenance therapy following autologous stem cell transplantation to improve responses among patients with #MM. Learn more: https://hubs.ly/Q03JL3X-0